Shares of Doximity, Inc. (NASDAQ:DOCS – Get Free Report) have been given an average recommendation of “Hold” by the fifteen analysts that are presently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, eleven have issued a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $28.73.
DOCS has been the subject of a number of research reports. SVB Leerink started coverage on shares of Doximity in a report on Monday, February 26th. They set a “market perform” rating and a $32.00 target price for the company. Needham & Company LLC reissued a “hold” rating on shares of Doximity in a report on Friday, May 17th. Morgan Stanley reaffirmed an “underweight” rating and issued a $25.00 price objective on shares of Doximity in a research note on Tuesday, April 23rd. Evercore ISI increased their target price on shares of Doximity from $28.00 to $29.00 and gave the stock an “in-line” rating in a report on Friday, May 17th. Finally, Leerink Partnrs reaffirmed a “market perform” rating on shares of Doximity in a report on Monday, February 26th.
Check Out Our Latest Research Report on Doximity
Insider Buying and Selling at Doximity
Institutional Trading of Doximity
Several hedge funds and other institutional investors have recently bought and sold shares of DOCS. Victory Capital Management Inc. raised its stake in shares of Doximity by 46.3% in the third quarter. Victory Capital Management Inc. now owns 27,083 shares of the company’s stock valued at $575,000 after acquiring an additional 8,575 shares during the period. Swiss National Bank lifted its stake in Doximity by 3.4% in the third quarter. Swiss National Bank now owns 240,500 shares of the company’s stock worth $5,103,000 after purchasing an additional 7,900 shares during the last quarter. Charles Schwab Investment Management Inc. grew its stake in shares of Doximity by 10.7% during the third quarter. Charles Schwab Investment Management Inc. now owns 699,066 shares of the company’s stock valued at $14,834,000 after buying an additional 67,363 shares during the last quarter. HighTower Advisors LLC grew its stake in shares of Doximity by 123.6% during the third quarter. HighTower Advisors LLC now owns 66,000 shares of the company’s stock valued at $1,400,000 after buying an additional 36,485 shares during the last quarter. Finally, State Board of Administration of Florida Retirement System lifted its stake in shares of Doximity by 3.8% during the 3rd quarter. State Board of Administration of Florida Retirement System now owns 89,824 shares of the company’s stock worth $1,906,000 after acquiring an additional 3,330 shares during the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.
Doximity Trading Up 0.9 %
Shares of DOCS stock opened at $29.86 on Monday. The stock has a market capitalization of $5.54 billion, a P/E ratio of 41.47, a P/E/G ratio of 5.58 and a beta of 1.23. The firm’s 50 day moving average is $26.22 and its 200 day moving average is $27.21. Doximity has a 12-month low of $19.71 and a 12-month high of $36.29.
Doximity (NASDAQ:DOCS – Get Free Report) last posted its quarterly earnings data on Thursday, May 16th. The company reported $0.20 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.04. The company had revenue of $118.06 million during the quarter, compared to analysts’ expectations of $116.46 million. Doximity had a return on equity of 17.44% and a net margin of 31.04%. As a group, equities analysts predict that Doximity will post 0.74 earnings per share for the current year.
Doximity Company Profile
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Read More
- Five stocks we like better than Doximity
- 3 Warren Buffett Stocks to Buy Now
- MarketBeat Week in Review – 6/10 – 6/14
- What Are Trending Stocks? Trending Stocks Explained
- Top 5 High-Performance Cryptocurrency ETFs to Watch
- Short Selling: How to Short a Stock
- 3 Stocks That Plummeted After the Post-Fed Speech Crash
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.